Skip to main content
OpenTrials

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

82 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Completed

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Gunma, Japan
  • GSK Investigational Site Hyōgo, Japan
  • GSK Investigational Site Hyōgo, Japan
View all 34 locations
View Trial Details
Completed

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

NCT03298061

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

NCT03895801

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • Clinical Site Leuven, Belgium
  • Clinical Site Liège, Belgium
  • Clinical Site Hradec Králové, Czechia
  • Clinical Site Prague, Czechia
View all 76 locations
View Trial Details
Completed

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

NCT00315393

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

NCT02115997

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • Yashoda Hospital Hyderabad, Andhra Pradesh, India
  • MULJIBHAI PATEL UROLOGICAL HOSPITAL; Nephrology Gujarat, India
  • Medanta-The Medicity Gurgaon, Haryana, India
  • Fortis Memorial Research Instititute Gurgaon, Haryana, India
View Trial Details
Completed

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

NCT01988506

Conditions
Ankylosing Spondylitis, Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +90 more
Locations
  • Henri Mondor - Médecine Interne Créteil, France
  • Médecine interne - Hôpital Saint-Antoine Paris, France
  • Service de médecine vasculaire - HEGP Paris, France
  • Service d' Hépato Gastro Entérologie - Hôpital SAINT-ANTOINE Paris, Île-de-France Region, France
View Trial Details

Related conditions